特色产品

产品编号	产品名称	CAS号	产品描述
V0955	Ferrostatin-1 (Fer-1)	347174-05-4	Ferrostatin-1 (also named as Fer-1) is a potent and selective inhibitor of ferroptosis with EC50 of 60 nM.
V4653	Deruxtecan	1599440-13-7	Deruxtecan (DS-8201a; DS8201a; exatecan analog; DX-8951 analog), a drug-linker conjugate for antibody-drug conjugate (ADC, Patritumab deruxtecan orU3-1402), is a novel, potent toxin and linker moiety of DS-8201.
V40915	Defibrotide sodium(Defitelio)	83712-60-1	Defibrotide (Defitelio), a polydeoxyribonucleotidesodiumsaltextractedfrommammalianorgans, is a mixture of single-stranded oligonucleotides withliver protection, anti-inflammatory, antithrombotic, profibrinolytic, and anti-ischemic properties.
V37614	Molnupiravir (EIDD-2801, MK-4482)	2349386-89-4	Molnupiravir (EIDD-2801;MK4482; prodrug-EIDD1931;MK-4482; trade name Lagevrio) is a novel, potent and orally bioavailable prodrug of the ribonucleoside analog EIDD-1931 with a broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as COVID-19, SARS-CoV-2, MERS-CoV, SARS-CoV.
V31465	FB23-2	2243736-45-8	FB23-2 (FB23-2; FB-23-2; FB 232) is a novel, potent and selective inhibitor of mRNA N6-methyladenosine (m6A) demethylase FTO with potential anticancer activity.
V8466	AZ1	2165322-94-9	AZ1 is a novel and potent dual inhibitor of the USP25/28 deubiquitinating enzyme subfamily with potential anticancer activity.
V7143	2-NBDG	186689-07-6	2-NBDG is a fluorescent analogue of glucose and an indicator used for measuring glucose uptake by bacteria and live mammalian cells and in tumor biopsies.
V1389	Doxorubicin HCl (adriamycin; NSC 123127)	25316-40-9	Doxorubicin HCl (formerly known as Adriamycin; FI 106; Adriblastina; DOXOCELL; Doxolem; NSC-123127 etc.) is an anthracycline antibiotic agent with anticancer activity.
V0954	Erastin	571203-78-6	Erastin is acell-permeable small molecule and potent ferroptosis activator by acting on mitochondrial VDAC with potential antineoplastic activity.
V0630	Pexidartinib (PLX3397; Turalio; CML261; FP113)	1029044-16-3	Pexidartinib (formerly PLX-3397; CML-261;FP-113; trade name Turalio) is an orally bioavailable and multi-targeted RTK (receptor tyrosine kinase) inhibitor of CSF-1R, Kit, and Flt3 with potential antineoplastic activity.